Community acquired pneumonia in internal medicine: A one-year retrospective study based on pneumonia severity index

International Journal of Immunopathology and Pharmacology

Volumn 18, Issue 3, 2005, Pages 575-586

  Riccioni, Graziano ^a,e   Di Pietro, V ^b   Staniscia, T ^a   De Feudis, L ^c   Traisci, G ^c   Capani, F ^b   Ferrara, G ^d   Di Ilio, E ^a   Di Tano, G ^a   D'Orazio, N ^a  

^a UNIVERSITY OF CHIETI   (Italy)

^b Policlinico SS Annunziata   (Italy)

^c Holy Spirit Civil Hospital   (Italy)

^d UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^e NONE   (Italy)

Author keywords

Community acquired pneumonia; Pneumonia severity index; Pneumonia therapy

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; CEFEPIME; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; CLARITHROMYCIN; LEVOFLOXACIN; PIPERACILLIN; TAZOBACTAM; TOBRAMYCIN;

ADOLESCENT; ARTICLE; COMMUNITY ACQUIRED PNEUMONIA; CONTROLLED STUDY; COST; DISEASE SEVERITY; DRUG COST; FEMALE; HEALTH CARE; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; ITALY; MALE; MEDICAL ASSESSMENT; PRIORITY JOURNAL; REDUCTION; RETROSPECTIVE STUDY; UNITED STATES; VALIDATION PROCESS; WARD;

EID: 27444434791     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463200501800318     Document Type: Article

References (44)

1. Mandell L.A. 1995. Community-acquired pneumonia - Etiology, epidemiology and treatment. Chest. 108:35S.
2. Center for Disease Control and Prevention. 1997. Premature death, monthly mortality and monthly physicians contacts. United States. Mort. Mortal. Wkly Rep. 46:556.
3. Marston B.J., J.F. Plouffe, T.M. jr File, B.A. Hackman, S.J. Salstrom, H.B. Lipman, M. S. Kolczak and R.F. Breiman. 1997. Incidence of community-acquired pneumonia requiring hospitalization. Results of a population-based active surveillance study in Ohio. The Community-based pneumonia Incidence Study Group. Arch. Int. Med. 157:1709.
4. Almirall J., J. Morato, F. Riera, A. Verdaguer, R. Priu, P. Coll, J. Vidal, L. Murgui, F. Valls and F. Catalan. 1993. Incidence of Community-acquired Pneumonia and Chlamydia pneumoniae infection: a prospective multicentre study. Eur. Resp. J. 6:14.
5. Woodhead M.A., J.T. Mac Farlane, J.S. Mc Cracken, D.H. Rose and R.G. Finch. 1987. Prospective study on the aetiology and outcome of pneumonia in the community. Lancet. 1:671.
6. Marrie T.J. 1994. Community-acquired pneumonia. Clin. Infect. Dis. 18:501.
7. British Thoracic Society. 2001. BTS Guidelines for the management of Community Acquired Pneumonia in adults. Thorax 56:1.
8. Niederman M.S., J.S. McCombs, A.N. Unger, A. Kumar and R. Popovian. 1998. The cost of treating community-acquired pneumonia. Clin. Ther. 20:820.
9. Torres A., J. Serra-Batlles, A. Ferrer, P. Jimenez, R. Celis, E. Cobo and R. Rodriguez-Roisin. 1991. Severe community-acquired pneumonia. Epidemiology and prognostic factors. Ann. Rev. Resp. Dis. 144:312.
10. Lim I., D.R. Shaw, D.P. Stanley, R. Lumb and G. McLennan. 1989. A prospective hospital study of the aetiology of community-acquired pneumonia. Med. J. Aus. 151:87.
11. Leroy O., H. Georges, C. Beuscart, B. Guery, C. Coffinier, C. Vandenbussche, D. Thevenin and G. Beaucaire. 1996. Severe community-acquired pneumonia in intensive care units: prospective validation of a prospective score. Int. Care. Med. 22:1307.
12. Fang G.D., M. Fine, J. Orloff, D. Arisumi, V.L. Yu, W. Kapoor, J.T. Grayston, S.P. Wang, R. Kohler and R.R. Muder. 1990. New and emerging etiologies for community-acquired pneumonia with implications for therapy: a prospective multicenter study of 359 cases. Medicine 69:307.
13. Fine M.J., T.E. Auble, D.M. Yealy, B.H. Hanusa, L.A. Weissfeld, D.E. Singer, C.M. Coley, T.J. Marrie and W.N. Kapoor. 1997. A prediction rule to identify low-risk patients with community-acquired pneumonia. N. Eng. J. Med. 336:243.
14. Fine M.J., M.A. Smith, C.A. Carson, S.S. Mutha, S.S. Sankey, L.A. Weissfeld and W.N. Kapoor. 1996. Prognosis and outcomes of patients with community-acquired pneumonia. A meta-analysis. JAMA 275:134.
15. Niederman M.S., L.A. Mandell, A. Anzueto, J.B. Bass, W.A. Broughton, G.D. Campbell, N. Dean, T. File, M.J. Fine, P.A. Gross, F. Martinez, T. J. Marrie, J. F. Plouffe, J. Ramirez, G.A. Sarosi, A. Torres, R. Wilson, V.L. Yu and The American Thoracic Society. 2001. Guidelines for the management of adults with community-acquired pneumonia: diagnosis, assessment of severity, antimicrobial therapy and prevention. Am. J. Respir. Crit. Care. Med. 163:1730.
16. ERS Task Force Report. 1998. Guidelines for management of adult community-acquired lower respiratory tract infections. European Respiratory Society. Eur. Respir. J. 11:986.
17. Farr B.M., A.J. Sloman and M.J. Fisch. 1991. Predicting death in patients hospitalized for community-acquired pneumonia. Ann. Intern. Med. 115:428.
18. Neill A.M., I.R. Martin, R. Weir, R. Anderson, A. Chereshsky, M.J. Epton, R. Jackson, M. Schousboe, C. Frampton, S. Hutton, S.T. Chambers and G.I. Town. 1996. Community-acquired pneumonia: aetiology and usefulness of severity criteria on admission. Thorax 51:1010.
19. Atlas S.J., T.I. Benzer, L.H. Borowsky, Y. Chang, D.C. Burnham, J.P. Metlay, E.A. Halm and D.E. Singer. 1998. Safely increasing the proportion of patients with Community-acquired pneumonia treated as outpatients. Arch. Intern. Med. 158:1350.
20. Marrie T.J., C.Y. Lau, S.L. Wheeler, C.J. Wong, M.K. Vandervoort and B.C. Feagan. 2000. A controlled trial of a critical pathway for treatment of community-acquired pneumonia. JAMA 283:749.
21. Ruiz M., S. Ewig, A. Torres, F. Arancibia, F. Marco, J. Mensa, M. Sanchez and J.A. Martinez. 1999. Etiology of community-acquired pneumonia: impact of age, comorbidity and severity. Am. J. Respir. Crit. Care Med. 160:397.
22. Zalacain R., A. Torres, R. Celis, J. Blanquer, J. Aspa, L. Esteban, R. Menendez, R. Blanquer, L. Borderias, Pneumonia in the elderly working group and Area de Tuberculosis e Infecciones Respiratorias. 2003. Community-acquired pneumonia in the elderly: Spanish multicentre study. Eur. Respir. J. 21:294.
23. España P.P., A. Capelastegui, J.M. Quintana, A. Soto, I. Gorordo, M. Garcia-Urbaneja and A. Bilbao. 2003. A prediction rule to identify allocation of inpatient care in community-acquired pneumonia. Eur. Respir. J. 21:695.
24. Ramirez J.A. 1995. Switch therapy in adult patients with pneumonia. Clin. Pulm. Med. 2:327.
25. Weingarten S.R., M.S. Riedinger, P. Hobson, M.S. Noah, B. Johnson, G. Giugliano, J. Norian, M.J. Belman and A.G. Ellrodt. 1996. Evaluation of a pneumonia practice guideline in an interventional trial. Am. J. Respir. Crit. Care. Med. 153:1110.
26. Halm E.A., M.J. Fine, T.J. Marrie, C.M. Coley, W.N. Kapoor, D.S. Obrosky and D.E. Singer. 1999 Time to clinical stability in patients hospitalized with community-acquired pneumonia: implications for practice guidelines. JAMA 281:231.
27. Rhew D.C., D. Hackner, L. Henderson, A.G. Ellrodt and S.R. Weingarten. 1998. The clinical benefit of in-hospital observation in 'low-risk' pneumonia patients after conversion from parenteral to oral antimicrobial therapy. Chest 113:142.
28. Fine M.J., D.E. Singer, A.L. Phelps, B.H. Hanusa and W.H. Kapoor. 1993. Differences in length of hospital stay in patients with community-acquired pneumonia: a prospective four hospital-study. Med. Care 31:371.
29. McCormick D., M.J. Fine, C.M. Coley, T.J. Marrie, J.R. Lave, D.S. Obrosky, W.N. Kapoor and D.E. Singer. 1999. Variation in length of hospital stay in patients with community-acquired pneumonia: are shorter stays associated with worse medical outcomes? Am. J. Med. 107:5.
30. Dean N.C. 1999. Use of prognostic scoring and outcome assessment tools in the admission decision for community-acquired pneumonia. Clin. Chest. Med. 20:521.
31. Agenzia per i Servizi Sanitari Regionali. 2003. Livelli essenziali di assistenza: la prima mappa dettagliata delle prestazioni e dei costi. Monitor 5:11.
32. Bondonio P. and M. Enandi. 1995. I tempi ed i costi di lavoro associati al trattamento farmacologico: analisi di alcune opportunità di risparmio. Farmacoeconomia 3:36.
33. Marras T.K., C. Guitierrez and C.K. Chan. 2000. Applying a prediction rule to identify low-risk patients with Community-acquired pneumonia. Chest 118:1339.
34. Stahl J.E., M. Barza, J. Desjardin, R. Martin and M.H. Eckman. 1999. Effect of macrolides as part of initial empiric therapy on length of stay in patients hospitalised with community-acquired pneumonia. Arch. Intern. Med. 159:2576.
35. Heffelfinger J.D., S.F. Dowell, J.H. Jorgensen, K.P. Klugman, L.R. Mabry, D.M. Musher, J.F. Plouffe, A. Rakowsky, A. Schuchat and C.G. Whitney. 2000. Management of community-acquired pneumonia in the era of pneumococcal resistance: a report from the drug-resistant Streptococcus pneumoniae Therapeutic Working Group. Arch. Intern. Med. 160:1399.
36. Coley C.M., Y.H. Li, A.R. Medsger, T.J. Marrie, M.J. Fine, W.N. Kapoor, J.R. Lave, A.S. Detsky and M.C. Weinstein. 1996. Preference for home vs hospital care among low-risk patients with community-acquired pneumonia. Arch. Intern. Med. 156:1565.
37. Viegi G., R. Pistelli and F. Falcone. 2000. Risultati preliminari dell'indagine epidemiologica italiana sulle polmoniti acquisite in comunità (EPI-CAP 99). Rass. Pat. App. Resp. 15:361.
38. Grasela T.H. Jr., J.A. Paladino, J.J. Schentag, D. Huepenbecker, J. Rybacki, J.B. Purcell and J.B. Fiedler. 1991. Clinical and economic impact of oral ciprofloxacin as follow-up to parenteral antibiotics. DICP 25:857.
39. Feagan B.C., T.J. Marrie, C.Y. Lau, S.L. Wheeler, C.J. Wong and M.K. Vandervoort Treatment and outcomes of community-acquired pneumonia. CMAJ 162:1415.
40. Rhew D.C., M.S. Riedinger, M. Sandhu, C. Bowers, N. Greengold and S.R. Weingarten. 1998. A prospective multicenter study of pneumonia practice guideline. Chest 114:115.
41. Siegel R.E., N.A. Halperin, P.L. Almenoff, A. Lee and J.C. Greene. 1996. A prospective randomized study of inpatient IV antibiotics for community-acquired pneumonia: the optimal duration of therapy. Chest 110:965.
42. Ramirez J.A., S. Vargas, G.W. Ritter, M.E. Brier, A. Wright, S. Smith, D. Newman, J. Burke, M. Mushtaq and A. Huang. 1999. Early switch therapy from intravenous to oral antibiotics and early hospital discharge: a prospective observational study of 200 consecutive patients with community-acquired pneumonia. Arch. Intern. Med. 159:2449.
43. Weingarten S.R., M.S. Riedinger, G. Varis, M.S. Noah, M.J. Belman, R.D. Meyer and A.G. Ellrodt. 1994. Identification of low-risk hospitalized patients with pneumonia: implications for early conversion to oral antimicrobial therapy. Chest 105:1109.
44. Marrie T.J., R.W. Peeling, M. J. Fine, D.E. Singer, C.M. Coley and W.N. Kapoor. 1996. Ambulatory patients with community-acquired pneumonia: the frequency of atypical agents and clinical course. Am. J. Med. 101:508.